Fulgent Genetics holds 2022 annual meeting; all director nominees and proposals approved

Fulgent Genetics, Inc.

All four director nominees elected: Hsieh 15.9M for, Bolger 10.6M (5.6M withheld), Yen 12.3M, Marsh 12.9M.
Ratification of Deloitte & Touche as auditor for 2022: 21,789,084 for, 121,792 against.
Non-binding advisory approval of named executive officer compensation: 15,719,000 for, 405,690 against.
Advisory vote on frequency of say-on-pay: 16,052,536 for 1 year; board adopted one-year frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.